Mineralys Therapeutics, Inc. — Form D

Mineralys Therapeutics, Inc. of RADNOR, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-13. The offering totals $118.0M, of which $118.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (9)

NameRoleLocation
Srinivas AkkarajuDirectorPalo Alto, CA
Alexander AsamDirectorRadnor, PA
Jon CongletonDirectorRadnor, PA
Derek DiRoccoDirectorBoston, MA
Olivier LitzkaDirectorIrvine, CA
Takeshi TakahashiDirectorRadnor, PA
Brian Taylor SlingsbyDirectorRadnor, PA
Jon CongletonExecutive OfficerRadnor, PA
Adam LevyExecutive OfficerLos Gatos, CA

More